127 related articles for article (PubMed ID: 8548600)
1. Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression.
Oda Y; Wehrmann B; Radig K; Walter H; Röse I; Neumann W; Roessner A
Gen Diagn Pathol; 1995 Oct; 141(2):97-103. PubMed ID: 8548600
[TBL] [Abstract][Full Text] [Related]
2. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma.
Sulzbacher I; Träxler M; Mosberger I; Lang S; Chott A
Mod Pathol; 2000 Jun; 13(6):632-7. PubMed ID: 10874667
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study.
Wang J; Coltrera MD; Gown AM
Cancer Res; 1994 Jan; 54(2):560-4. PubMed ID: 7903911
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
Majumdar K; Radotra BD; Vasishta RK; Pathak A
Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of platelet-derived growth factor and its receptors in soft tissue malignant fibrous histiocytoma.
Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Kawamoto T; Hitora T; Nakatani T; Nagira K; Kurosaka M
Anticancer Res; 2003; 23(5b):4325-8. PubMed ID: 14666646
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
Yacoub L; Goldman H; Odze RD
Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
[TBL] [Abstract][Full Text] [Related]
9. Fas expression inversely correlates with metastatic potential in osteosarcoma cells.
Worth LL; Lafleur EA; Jia SF; Kleinerman ES
Oncol Rep; 2002; 9(4):823-7. PubMed ID: 12066216
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
Henriksen R; Funa K; Wilander E; Bäckström T; Ridderheim M; Oberg K
Cancer Res; 1993 Oct; 53(19):4550-4. PubMed ID: 8402626
[TBL] [Abstract][Full Text] [Related]
11. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma.
Sulzbacher I; Birner P; Trieb K; Träxler M; Lang S; Chott A
Mod Pathol; 2003 Jan; 16(1):66-71. PubMed ID: 12527715
[TBL] [Abstract][Full Text] [Related]
12. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
14. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
15. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
[TBL] [Abstract][Full Text] [Related]
16. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis.
de Jong JS; van Diest PJ; van der Valk P; Baak JP
J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic modification of human osteosarcoma cells with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
Ringbom-Anderson T; Sandberg M; Andersson G; Akerman KE
Cell Growth Differ; 1995 Apr; 6(4):457-64. PubMed ID: 7794813
[TBL] [Abstract][Full Text] [Related]
18. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
Oda Y; Sakamoto A; Shinohara N; Ohga T; Uchiumi T; Kohno K; Tsuneyoshi M; Kuwano M; Iwamoto Y
Clin Cancer Res; 1998 Sep; 4(9):2273-7. PubMed ID: 9748149
[TBL] [Abstract][Full Text] [Related]
19. Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression.
Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1993 Aug; 30(6):1127-34. PubMed ID: 8106073
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis.
Wen YH; Koeppen H; Garcia R; Chiriboga L; Tarlow BD; Peters BA; Eigenbrot C; Yee H; Steiner G; Greco MA
Hum Pathol; 2007 Aug; 38(8):1184-91. PubMed ID: 17509661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]